Previous 10 | Next 10 |
Medigus (NASDAQ: MDGS ) +76% on first order for COVID-19 blood test . More news on: Medigus Ltd., Myomo, Inc., Akari Therapeutics, Plc, Stocks on the move, , Read more ...
Ellington Financial EFC +54% as book value holds up . More news on: Myomo, Inc., AG Mortgage Investment Trust, Inc., Anworth Mortgage Asset Corporation, Stocks on the move, , Read more ...
Myomo (NYSEMKT: MYO ) jumps 24% premarket on average volume in reaction to its announcement that more than 700 people are waiting for insurance reimbursement for its MyPro powered arm brace, up from 594 at the end of 2019. Backlog of authorized units has increased to 80 from 53...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported its pipeline of MyoPro candidates continu...
NEW YORK, NY / ACCESSWIRE / March 18, 2020 / Myomo, Inc. (NYSE American:MYO) - A wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will be presenting at this year's Spring Investor Summit on March 2...
Myomo, Inc. (MYO) Q4 2019 Earnings Conference Call March 12, 2020 4:15 PM ET Company Participants Kim Golodetz – Investor Relations-LHA Paul Gudonis – Chief Executive Officer Dave Henry – Chief Financial Officer Conference Call Participants Scott Henry ...
Myomo (NYSEMKT: MYO ): Q4 GAAP EPS of -$4.81 misses by $0.22 . Revenue of $1.52M (+70.8% Y/Y) beats by $0.12M . Press Release More news on: Myomo, Inc., Earnings news and commentary, Healthcare stocks news, ,
Direct Billing Represents 50% of Fourth Quarter Revenue Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb para...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”) a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the closing of its previously announced und...
Gainers: Myomo (NYSEMKT: MYO ) +48% . More news on: Myomo, Inc., Enphase Energy, Inc., Altisource Asset Management Corporation, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-10 17:00:05 ET Scott Henry from Industrial Alliance Securities issued a price target of $5.75 for MYO on 2024-07-10 15:33:00. The adjusted price target was set to $5.75. At the time of the announcement, MYO was trading at $4.97. The overall price target consensus...
2024-07-10 16:15:02 ET Alliance Global Partners analyst issues BUY recommendation for MYO on July 10, 2024 03:33PM ET. The previous analyst recommendation was Buy. MYO was trading at $4.97 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
2024-07-09 10:30:11 ET Lake Street analyst issues BUY recommendation for MYO on July 9, 2024 08:45AM ET. The previous analyst recommendation was Buy. MYO was trading at $4.07 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst...